Peroxiredoxin Involvement in the Initiation and Progression of Human Cancer

被引:63
作者
Hampton, Mark B. [1 ]
Vick, Kate A. [1 ]
Skoko, John J. [2 ,3 ]
Neumann, Carola A. [2 ,3 ]
机构
[1] Univ Otago, Ctr Free Rad Res, Dept Pathol, POB 4345, Christchurch 8140, New Zealand
[2] Univ Pittsburgh, Womens Canc Res Ctr, Ctr Canc, Pittsburgh, PA 15221 USA
[3] Univ Pittsburgh, Dept Pharmacol & Chem Biol, 204 Craft Ave, Pittsburgh, PA 15221 USA
关键词
peroxiredoxins; hydrogen peroxide; redox signaling; cancer biology; EPITHELIAL-MESENCHYMAL TRANSITION; AURANOFIN INDUCES APOPTOSIS; CISPLATIN-INDUCED APOPTOSIS; ANDROGEN RECEPTOR-ACTIVITY; HYPOXIA-INDUCIBLE FACTORS; NF-KAPPA-B; LUNG-CANCER; THIOREDOXIN REDUCTASE; HYDROGEN-PEROXIDE; COLORECTAL-CANCER;
D O I
10.1089/ars.2017.7422
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Significance: It has been proposed that cancer cells are heavily dependent on their antioxidant defenses for survival and growth. Peroxiredoxins are a family of abundant thiol-dependent peroxidases that break down hydrogen peroxide, and they have a central role in the maintenance and response of cells to alterations in redox homeostasis. As such, they are potential targets for disrupting tumor growth. Recent Advances: Genetic disruption of peroxiredoxin expression in mice leads to an increased incidence of neoplastic disease, consistent with a role for peroxiredoxins in protecting genomic integrity. In contrast, many human tumors display increased levels of peroxiredoxin expression, suggesting that strengthened antioxidant defenses provide a survival advantage for tumor progression. Peroxiredoxin inhibitors are being developed and explored as therapeutic agents in different cancer models. Critical Issues: It is important to complement peroxiredoxin knockout and expression studies with an improved understanding of the biological function of the peroxiredoxins. Although current results can be interpreted within the context that peroxiredoxins scavenge hydroperoxides, some peroxiredoxin family members appear to have more complex roles in regulating the response of cells to oxidative stress through protein interactions with constituents of other signaling pathways. Future Directions: Further mechanistic information is required for understanding the role of oxidative stress in cancer, the function of peroxiredoxins in normal versus cancer cells, and for the design and testing of specific peroxiredoxin inhibitors that display selectivity to malignant cells.
引用
收藏
页码:591 / 608
页数:18
相关论文
共 189 条
  • [1] Functional switching of a novel prokaryotic 2-Cys peroxiredoxin (PpPrx) under oxidative stress
    An, Byung Chull
    Lee, Seung Sik
    Lee, Eun Mi
    Lee, Jae Taek
    Wi, Seung Gon
    Jung, Hyun Suk
    Park, Woojun
    Lee, Sang Yeol
    Chung, Byung Yeoup
    [J]. CELL STRESS & CHAPERONES, 2011, 16 (03) : 317 - 328
  • [2] Analysis of the inhibition of mammalian thioredoxin, thioredoxin reductase, and glutaredoxin by cis-diamminedichloroplatinum (II) and its major metabolite, the glutathione-platinum complex
    Arnér, ESJ
    Nakamura, H
    Sasada, T
    Yodoi, J
    Holmgren, A
    Spyrou, G
    [J]. FREE RADICAL BIOLOGY AND MEDICINE, 2001, 31 (10) : 1170 - 1178
  • [3] A phase IB trial of 24-hour intravenous PX-12, a thioredoxin-1 inhibitor, in patients with advanced gastrointestinal cancers
    Baker, A. F.
    Adab, K. N.
    Raghunand, N.
    Chow, H. H. S.
    Stratton, S. P.
    Squire, S. W.
    Boice, M.
    Pestano, L. A.
    Kirkpatrick, D. L.
    Dragovich, T.
    [J]. INVESTIGATIONAL NEW DRUGS, 2013, 31 (03) : 631 - 641
  • [4] Differential Expression of Peroxiredoxins in Prostate Cancer: Consistent Upregulation of PRDX3 and PRDX4
    Basu, Anamika
    Banerjee, Hiya
    Rojas, Heather
    Martinez, Shannalee R.
    Roy, Sourav
    Jia, Zhenyu
    Lilly, Michael B.
    De Leon, Marino
    Casiano, Carlos A.
    [J]. PROSTATE, 2011, 71 (07) : 755 - 765
  • [5] Increased sensitivity of human colon cancer cells to DNA cross-linking agents after GRP78 up-regulation
    Belfi, CA
    Chatterjee, S
    Gosky, DM
    Berger, SJ
    Berger, NA
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 257 (02) : 361 - 368
  • [6] Mitochondrial peroxiredoxin 3 is rapidly oxidized in cells treated
    Brown, Kristin K.
    Eriksson, Sofi E.
    Arner, Elias S. J.
    Hampton, Mark B.
    [J]. FREE RADICAL BIOLOGY AND MEDICINE, 2008, 45 (04) : 494 - 502
  • [7] Mitochondrial respiratory chain involvement in peroxiredoxin 3 oxidation by phenethyl isothiocyanate and auranofin
    Brown, Kristin K.
    Cox, Andrew G.
    Hampton, Mark B.
    [J]. FEBS LETTERS, 2010, 584 (06): : 1257 - 1262
  • [8] Budanov Andrei V, 2014, Subcell Biochem, V85, P337, DOI 10.1007/978-94-017-9211-0_18
  • [9] Expression and clinical value of peroxiredoxin-1 in patients with pancreatic cancer
    Cai, C. -Y.
    Zhai, L. -L.
    Wu, Y.
    Tang, Z. -G.
    [J]. EJSO, 2015, 41 (02): : 228 - 235
  • [10] Prdx1 inhibits tumorigenesis via regulating PTEN/AKT activity
    Cao, Juxiang
    Schulte, Jennifer
    Knight, Alexander
    Leslie, Nicholas R.
    Zagozdzon, Agnieszka
    Bronson, Roderick
    Manevich, Yefim
    Beeson, Craig
    Neumann, Carola A.
    [J]. EMBO JOURNAL, 2009, 28 (10) : 1505 - 1517